trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Stroke D020521 32 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Mastocytoma D034801 3 associated lipids
Genomic Instability D042822 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Carbajal A et al. A novel method for purification of polymerizable tubulin with a high content of the acetylated isotype. 2013 Biochem. J. pmid:23140207
Gang H et al. Epigenetic regulation of canonical TNFα pathway by HDAC1 determines survival of cardiac myocytes. 2013 Am. J. Physiol. Heart Circ. Physiol. pmid:23585133
Yacqub-Usman K et al. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. 2013 Endocrinology pmid:23539512
Saha A et al. Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. 2013 Bioorg. Med. Chem. pmid:23719282
Xu M et al. Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144737
Wang X et al. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells. 2013 Mol. Carcinog. pmid:22121107
Li Y et al. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. 2013 Mol. Cancer pmid:23379261
Yang H et al. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. 2013 Biochem. Pharmacol. pmid:23643933
Koch M et al. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. 2013 Biochem. Pharmacol. pmid:23396090
Tang X et al. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. 2012-2013 Cancer Biomark pmid:23321465
Hou W et al. Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. 2012 Nov-Dec J. Androl. pmid:22556385
Darlyuk-Saadon I et al. The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22989952
Guo X et al. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells. 2012 May-Jun Cell. Immunol. pmid:22776176
Mehdi O et al. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). 2012 Mar-Apr Pancreatology pmid:22487525
Hong X et al. Heparanase expression is associated with histone modifications in glioblastoma. 2012 Int. J. Oncol. pmid:22001963
Yang G et al. Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition. 2012 Cell Transplant pmid:21944777
Kadaja-Saarepuu L et al. Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells. 2012 Int. J. Oncol. pmid:21947346
Ekici M et al. Chromatin structure and expression of the AMPA receptor subunit Glur2 in human glioma cells: major regulatory role of REST and Sp1. 2012 J. Cell. Biochem. pmid:21948504
Ying H et al. Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB. 2012 PLoS ONE pmid:23166597
Baud MG et al. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. 2012 J. Med. Chem. pmid:22280363
Heller G et al. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. 2012 Clin. Cancer Res. pmid:22282464
Hirata Y et al. Anti-tumor activity of new orally bioavailable 2-amino-5-(thiophen-2-yl)benzamide-series histone deacetylase inhibitors, possessing an aqueous soluble functional group as a surface recognition domain. 2012 Bioorg. Med. Chem. Lett. pmid:22321215
Sawai K et al. Epigenetic status and full-term development of bovine cloned embryos treated with trichostatin A. 2012 J. Reprod. Dev. pmid:22322145
Banerjee A et al. Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models. 2012 Am. J. Respir. Cell Mol. Biol. pmid:22298527
Otsuji TG et al. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes. 2012 PLoS ONE pmid:22984602
Ma P et al. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22223663
Szablowska-Gadomska I et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. 2012 Acta Neurobiol Exp (Wars) pmid:23377265
Wang B et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. 2012 Free Radic. Biol. Med. pmid:22226832
Liu H et al. Inhibition of class II histone deacetylase blocks proliferation and promotes neuronal differentiation of the embryonic rat neural progenitor cells. 2012 Acta Neurobiol Exp (Wars) pmid:23377267
Barrasa JI et al. Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells. 2012 Biochim. Biophys. Acta pmid:22227581
Becker JR et al. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. 2012 Cardiovasc. Res. pmid:22198505
Hsu YF et al. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells. 2012 Biochim. Biophys. Acta pmid:22155142
Bebenek IG et al. CYP2S1 is negatively regulated by corticosteroids in human cell lines. 2012 Toxicol. Lett. pmid:22155357
Schor IE et al. Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. 2012 PLoS ONE pmid:23152763
Mostovich LA et al. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. 2012 Epigenetics pmid:22805760
Zou Y et al. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. 2012 J Hematol Oncol pmid:22747680
Scholl C et al. Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain. 2012 BMC Genomics pmid:22748179
Soleymani Fard S et al. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22749740
Brose RD et al. Activation of the stress proteome as a mechanism for small molecule therapeutics. 2012 Hum. Mol. Genet. pmid:22752410
Yoshida A et al. Aberrant spikelet and panicle1, encoding a TOPLESS-related transcriptional co-repressor, is involved in the regulation of meristem fate in rice. 2012 Plant J. pmid:22136599
Shen T et al. Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells. 2012 Int. J. Biochem. Cell Biol. pmid:22138223
Rossi LE et al. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. 2012 J. Leukoc. Biol. pmid:22124136
Kim Y et al. Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein. 2012 J. Biol. Chem. pmid:22679019
Royce SG et al. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. 2012 Arch. Immunol. Ther. Exp. (Warsz.) pmid:22684086
Zhang YW et al. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. 2012 PLoS ONE pmid:22701735
Mitchell MD et al. Epigenetic regulation of cytokine production in human amnion and villous placenta. 2012 Mediators Inflamm. pmid:22665947
Fan LX et al. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation. 2012 Kidney Int. pmid:21900881
Zhu L et al. Hyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal rats. 2012 Pediatr. Pulmonol. pmid:21905265
Balaguer TM et al. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. 2012 BMC Mol. Biol. pmid:22846052
Yang F et al. Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte. 2012 Int. J. Dev. Biol. pmid:23417411